Medicinal products included in the General Medical Services Scheme must conform to certain published criteria. One of the criteria is that the product must be an "allopathic" medicinal product which is the subject of a current product authorisation granted by the Minister for Health. The granting of such an authorisation indicates that the National Drugs Advisory Board is satisfied as to the quality, safety and efficacy of the product concerned.
There is a wide range of alternative medicines available in respect of which quality, safety and efficacy has not been established. The Deputy will appreciate that the question of financial provision towards subsidising the cost of such treatment could not be justified.